Innova Captab growth over the years

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Compounded a year1 yr2 yr
Revenue+31.1%+22.8%
EBITDA+30.5%+25.4%
Net Income+11.6%+23.2%
EPS (adj.)+11.6%+23.2%
Total Assets+16.3%+18.0%
Total Equity+12.7%+14.1%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

INNOVACAP₹1,049.70

Innova Captab Limited

· Pharma & Health
₹ CrorePeersMOREPENLABIOLCPFDCSENORESSANOFIORCHPHARMAGUJTHEMRPGLIFEMcap ₹6,007 Cr
Annuals · FY-end closes
Compounded Growth
Annuals · CAGR %
1Y
CAGR
2Y
CAGR
Revenue+31.1+22.8
EBITDA+30.5+25.4
Net Income+11.6+23.2
EPS (adj.)+11.6+23.2
Total Assets+16.3+18.0
Total Equity+12.7+14.1
CAGR from filed annuals — needs positive start & end values.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.